Glyphosate Chalks Up Another Court Victory

The tide in the nation’s courtrooms against glyphosate appears to be turning. Some months ago, I reported on one of the first legal wins enjoyed by the popular herbicide, when a California jury ruled in that a rare form of cancer in one young boy was not caused by glyphosate. At the time, I wondered if this would be a “one-time thing” for glyphosate in its courtroom battles or the start of future legal victories as well.

And now, I have an answer. In mid-December, a different California jury found that Bayer’s Roundup weedkiller was not the cause of a woman’s non-Hodgkin’s lymphoma. The jury in San Bernardino County found that Donnetta Stephens’ cancer was not caused by her exposure between 1985 and 2017 to glyphosate.

Advertisement

So, with two court wins under its belt (and in California, no less), glyphosate producer Bayer is probably feeling a little bit better about its future prospects for fighting against still-pending lawsuits. In addition, the company has petitioned to the U.S. Supreme Court to review its first trial loss considering glyphosate, the $25 million judgement against the company in the case of Edwin Hardeman.

Top Articles
Phospholutions Inc. Appoints Research and Development Vice President Dr. Krishna Maruvada, to Propel Sustainable Fertilizer Technology

Bayer formally petitioned the court to hear its appeal in August. And on December 10, the high court asked President Joe Biden’s administration for its views on whether the justices should hear company’s bid to dismiss claims by customers who contend its Roundup weedkiller causes cancer. Bayer said in a released statement that it was “encouraged by the court’s announcement, which often indicates the justices are interested in hearing a case.”

Do you think the Supreme Court will hear the glyphosate appeal?

View Results

Loading ... Loading ...

With many eyes upon the Supreme Court already for myriad other reasons, it will be interesting to see what the high court might decide regarding glyphosate. Stay tuned . . .

0
Advertisement